人类乳头状瘤病毒33抗体

Quantity size:

0.2ml

Concentration:

1mg/ml  人类乳头状瘤病毒33抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that人类乳头状瘤病毒33抗体 the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. 
Human papillomaviruses 人类乳头状瘤病毒33抗体(HPV) are small DNA viruses which infect epithelia of the skin and mucosa. Over 90 types have been identified and they mostly cause a variety of benign lesions such as warts and verrucae. However, some subtypes, notably types 16 and 18, 31 and 33, have been confirmed as agents which cause cervical cancer.

人类乳头状瘤病毒33抗体Also known as:

E7 protein [Human papillomavirus type 33]; Human Papilloma Virus; Human papillomavirus type 33; Human papillomavirus type 33; Protein 33; early protein E7 [Human papillomavirus type 33].

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: HPV33/HPV58.

●

Immunogen: KLH conjugated synthetic peptide derived from HPV33 E7.

●

人类乳头状瘤病毒33抗体Predicted Molecular Weight: 11kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl452Ge01甲状腺素(T4)多克隆抗体Polyclonal Antibody to Thyroxine (T4)

kl344Hu51平滑肌肌动蛋白γ2(ACTγ2)多克隆抗体Polyclonal Antibody to Actin Gamma 2, Smooth Muscle (ACTg2)

kl344Mu51平滑肌肌动蛋白γ2(ACTγ2)多克隆抗体Polyclonal Antibody to Actin Gamma 2, Smooth Muscle (ACTg2)

kl344Ra51平滑肌肌动蛋白γ2(ACTγ2)多克隆抗体Polyclonal Antibody to Actin Gamma 2, Smooth Muscle (ACTg2)

kl391Hu52肌动蛋白γ1(ACTγ1)多克隆抗体Polyclonal Antibody to Actin Gamma 1 (ACTg1)

kl391Mu52肌动蛋白γ1(ACTγ1)多克隆抗体Polyclonal Antibody to Actin Gamma 1 (ACTg1)

kl391Ra51肌动蛋白γ1(ACTγ1)多克隆抗体Polyclonal Antibody to Actin Gamma 1 (ACTg1)

kl341Hu51心肌肌动蛋白α1(ACTC1)多克隆抗体Polyclonal Antibody to Actin Alpha 1, Cardiac Muscle (ACTC1)

kl341Mu51心肌肌动蛋白α1(ACTC1)多克隆抗体Polyclonal Antibody to Actin Alpha 1, Cardiac Muscle (ACTC1)

kl341Ra51心肌肌动蛋白α1(ACTC1)多克隆抗体Polyclonal Antibody to Actin Alpha 1, Cardiac Muscle (ACTC1)

kl119Hu01金属硫蛋白1(MT1)多克隆抗体Polyclonal Antibody to Metallothionein 1 (MT1)

kl119Mu01金属硫蛋白1(MT1)多克隆抗体Polyclonal Antibody to Metallothionein 1 (MT1)

kl119Ra01金属硫蛋白1(MT1)多克隆抗体Polyclonal Antibody to Metallothionein 1 (MT1)

kl119Rb52金属硫蛋白1(MT1)多克隆抗体Polyclonal Antibody to Metallothionein 1 (MT1)

kl868Hu01金属硫蛋白2(MT2)多克隆抗体Polyclonal Antibody to Metallothionein 2 (MT2)

kl868Mu01金属硫蛋白2(MT2)多克隆抗体Polyclonal Antibody to Metallothionein 2 (MT2)

kl868Ra01金属硫蛋白2(MT2)多克隆抗体Polyclonal Antibody to Metallothionein 2 (MT2)

kl868Rb52金属硫蛋白2(MT2)多克隆抗体Polyclonal Antibody to Metallothionein 2 (MT2)

kl339Hu01肌钙蛋白C(TNC)多克隆抗体Polyclonal Antibody to Troponin C (TNC)

kl339Ra01肌钙蛋白C(TNC)多克隆抗体Polyclonal Antibody to Troponin C (TNC)

kl339Mu01肌钙蛋白C(TNC)多克隆抗体Polyclonal Antibody to Troponin C (TNC)